{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:29:04Z","timestamp":1783693744078,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"7-8","license":[{"start":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:00:00Z","timestamp":1444780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00508-015-0870-z","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T07:47:55Z","timestamp":1444808875000},"page":"299-303","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Graves\u2019 ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature"],"prefix":"10.1007","volume":"128","author":[{"given":"Ozan Cem","family":"Guler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Onal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gungor","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,14]]},"reference":[{"key":"870_CR1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1748-717X-6-46","volume":"6","author":"M Abboud","year":"2011","unstructured":"Abboud M, Arabi A, Salti I, et al. Outcome of thyroid associated ophthalmopathy treated by radiation therapy. Radiat Oncol. 2011;6:46.","journal-title":"Radiat Oncol"},{"issue":"1","key":"870_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijrobp.2010.08.053","volume":"82","author":"C Matthiesen","year":"2012","unstructured":"Matthiesen C, Thompson JS, Thompson D, et al. The efficacy of radiation therapy in the treatment of Graves\u2019 orbitopathy. Int J Radiat Oncol Biol Phys. 2012;82(1):117\u201323.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"870_CR3","first-page":"12","volume":"5","author":"V Kouloulias","year":"2013","unstructured":"Kouloulias V, Kouvaris J, Zygogianni A, et al. Efficacy and toxicity of radiotherapy for Graves\u2019 ophthalmopathy: the University of Athens experience. Head Neck Oncol. 2013;5(2):12.","journal-title":"Head Neck Oncol"},{"issue":"6","key":"870_CR4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/01676830.2011.615455","volume":"30","author":"JF Yim Li","year":"2011","unstructured":"Li Yim JF, Sandinha T, Kerr JM, et al. Low dose orbital radiotherapy for thyroid eye disease. Orbit. 2011;30(6):269\u201374.","journal-title":"Orbit"},{"issue":"3","key":"870_CR5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","volume":"121","author":"GB Bartley","year":"1996","unstructured":"Bartley GB, Fatourechi V, Kadrmas EF, et al. Clinical features of Graves\u2019 ophthalmopathy in an incidence cohort. Am J Ophthalmol. 1996;121(3):284\u201390.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"870_CR6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/bjo.88.1.72","volume":"88","author":"JM Kim","year":"2004","unstructured":"Kim JM, LaBree L, Levin L, et al. The relation of Graves\u2019 ophthalmopathy to circulating thyroid hormone status. Br J Ophthalmol. 2004;88(1):72\u20134.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"870_CR7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/OPX.0b013e3181ce5702","volume":"87","author":"A Kozaki","year":"2010","unstructured":"Kozaki A, Inoue R, Komoto N, et al. Proptosis in dysthyroid ophthalmopathy: a case series of 10,931 Japanese cases. Optom Vis Sci. 2010;87(3):200\u20134.","journal-title":"Optom Vis Sci"},{"issue":"3","key":"870_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.beem.2011.11.005","volume":"26","author":"C Marcocci","year":"2012","unstructured":"Marcocci C, Marino M. Treatment of mild, moderate-to-severe and very severe Graves\u2019 orbitopathy. Best Pract Res Clin Endocrinol Metab. 2012;26(3):325\u201337.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"3","key":"870_CR9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.ijrobp.2010.09.015","volume":"82","author":"CC Cardoso","year":"2012","unstructured":"Cardoso CC, Giordani AJ, Wolosker AM, et al. Protracted hypofractionated radiotherapy for Graves\u2019 ophthalmopathy: a pilot study of clinical and radiologic response. Int J Radiat Oncol Biol Phys. 2012;82(3):1285\u201391.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"870_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICU.0b013e3283560b2b","volume":"23","author":"PJ Dolman","year":"2012","unstructured":"Dolman PJ, Rath S. Orbital radiotherapy for thyroid eye disease. Curr Opin Ophthalmol. 2012;23(5):427\u201332.","journal-title":"Curr Opin Ophthalmol"},{"issue":"9","key":"870_CR11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00066-011-2220-z","volume":"187","author":"NP Nguyen","year":"2011","unstructured":"Nguyen NP, Krafft SP, Vos P, et al. Feasibility of tomotherapy for Graves\u2019 ophthalmopathy: dosimetry comparison with conventional radiotherapy. Strahlenther Onkol. 2011;187(9):568\u201374.","journal-title":"Strahlenther Onkol"},{"issue":"12","key":"870_CR12","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1210\/jc.2006-1105","volume":"91","author":"MN Stan","year":"2006","unstructured":"Stan MN, Garrity JA, Bradley EA, et al. Randomized, double-blind, placebo-controlled trial of long-acting release octreotide for treatment of Graves\u2019 ophthalmopathy. J Clin Endocrinol Metab. 2006;91(12):4817\u201324.","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"870_CR13","doi-asserted-by":"crossref","first-page":"5910","DOI":"10.1210\/jc.2004-0697","volume":"89","author":"AJ Dickinson","year":"2004","unstructured":"Dickinson AJ, Vaidya B, Miller M, et al. Double-blind, placebo-controlled trial of octreotide long-acting repeatable (LAR) in thyroid-associated ophthalmopathy. J Clin Endocrinol Metab. 2004;89(12):5910\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"870_CR14","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","volume":"326","author":"L Tallstedt","year":"1992","unstructured":"Tallstedt L, Lundell G, Torring O, et al. Occurrence of ophthalmopathy after treatment for Graves\u2019 hyperthyroidism. The Thyroid Study Group. N Engl J Med. 1992;326(26):1733\u20138.","journal-title":"N Engl J Med"},{"issue":"5","key":"870_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2169\/internalmedicine.53.1518","volume":"53","author":"Y Hiromatsu","year":"2014","unstructured":"Hiromatsu Y, Eguchi H, Tani J, et al. Graves\u2019 ophthalmopathy: epidemiology and natural history. Intern Med. 2014;53(5):353\u201360.","journal-title":"Intern Med"},{"issue":"2","key":"870_CR16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0360-3016(01)01814-4","volume":"52","author":"O Micke","year":"2002","unstructured":"Micke O, Seegenschmiedt MH, German Working Group on Radiotherapy in G. Consensus guidelines for radiation therapy of benign diseases: a multicenter approach in Germany. Int J Radiat Oncol Biol Phys. 2002;52(2):496\u2013513.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"870_CR17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","volume":"18","author":"L Bartalena","year":"2008","unstructured":"Bartalena L, Baldeschi L, Dickinson AJ, et al. Consensus statement of the European group on Graves\u2019 orbitopathy (EUGOGO) on management of Graves\u2019 orbitopathy. Thyroid. 2008;18(3):333\u201346.","journal-title":"Thyroid"},{"issue":"1","key":"870_CR18","first-page":"102","volume":"85","author":"GJ Kahaly","year":"2000","unstructured":"Kahaly GJ, Rosler HP, Pitz S, et al. Low- versus high-dose radiotherapy for Graves\u2019 ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab. 2000;85(1):102\u20138.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-015-0870-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-015-0870-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-015-0870-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T21:58:57Z","timestamp":1559080737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-015-0870-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,14]]},"references-count":18,"journal-issue":{"issue":"7-8","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s00508-015-0870-z","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,14]]}}}